Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Tissue engineering strategies for construction of artificial salivary glands based on decellularized scaffolds of rats.

Dai T., Shi L., Kong H., Zhao L., Wang Y., Cao Y.

Animal Study on Scar, published in Biomaterials (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Biomaterials (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41895021
DOI
10.1016/j.biomaterials.2026.124166

Abstract (original English)

Salivary gland (SG) hypofunction is a debilitating condition with no curative treatments. Tissue engineering based on decellularized scaffolds represents a promising regenerative strategy; however, its application to SGs has been limited by inadequate decellularization techniques and scarce cell sources. Here, we developed a novel perfusion-based decellularization method via the ductal and venous systems to generate rat submandibular gland scaffolds. This approach efficiently removed cellular components while optimally preserving the native three-dimensional architecture, key extracellular matrix (ECM) components, and the integrity of ductal and vascular networks. We then constructed artificial SGs by recellularizing these biomimetic scaffolds through the ductal route with salivary gland cells (SGCs), adipose-derived stromal cells (ADSCs), or SGC-pre-induced ADSCs. In vitro perfusion culture revealed that all cell sources, including transdifferentiated ADSCs, supported the formation of acinar-like structures and expressed the functional marker α-amylase (α-AMY), with peak performance observed at day 5. Upon in vivo transplantation, the tissue-engineered glands maintained partial α-AMY expression for up to 5 days, demonstrating short-term survival and function. However, graft longevity was limited beyond 7 days, primarily due to insufficient vascularization. Our study establishe

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsTissue EngineeringTissue ScaffoldsRatsSalivary GlandsRats, Sprague-DawleyMaleDecellularized Extracellular MatrixAdipose TissueCells, Cultured

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research